VALEO PHARMA
Valeo Pharma is devoted to providing healthcare professionals and patients with the highest quality specialty products and healthcare solutions. Valeo Pharma concentrates on the commercialization of specialized innovative products addressing the needs of patients suffering from complicated or rare diseases. The company's focus on respiratory/allergy, ophthalmology, and hospital specialty products demonstrates its dedication to providing vital healthcare solutions.
VALEO PHARMA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2003-01-01
Address:
Kirkland, Quebec, Canada
Country:
Canada
Website Url:
http://www.valeopharma.com
Total Employee:
101+
Status:
Active
Contact:
514-694-0150
Email Addresses:
[email protected]
Total Funding:
106.6 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Apple Mobile Web Clips Icon Google Font API WordPress SSL By Default Mobile Non Scaleable Content HSTS
Similar Organizations
Certara
Certara accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Repligen
Repligen is a biopharmaceutical company developing consumable products for the manufacture of biological drugs.
Sprout Pharmaceuticals
Sprout Pharmaceuticals is a medical company that develops products for the treatment of female sexual dysfunction.
Current Employees Featured
Founder
Stock Details
Investors List
Accord Financial, Inc. (U.S.)
Accord Financial, Inc. (U.S.) investment in Post-IPO Debt - Valeo Pharma
Sagard Healthcare Royalty Partners
Sagard Healthcare Royalty Partners investment in Post-IPO Debt - Valeo Pharma
Investissement Quebec
Investissement Quebec investment in Post-IPO Debt - Valeo Pharma
Official Site Inspections
http://www.valeopharma.com Semrush global rank: 3.9 M Semrush visits lastest month: 2.91 K
- Host name: host4.bizhostingservices.com
- IP address: 72.52.162.119
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
More informations about "Valeo Pharma"
Home - Valeo Pharma
Rooted in specialty pharma, Valeo is growing Canadian healthcare by licensing and acquiring Canadian rights to commercial stage, innovative, and proprietary drugs. Our current portfolio …See details»
VALEO PHARMA ANNOUNCES ORGANIZATIONAL CHANGES AND …
Nov 20, 2023 · Valeo expects to decrease its operating expenses by more than $2.0 million, on an annualized basis, through reorganizing and streamlining its organizational structure and …See details»
VALEO PHARMA ANNOUNCES LEADERSHIP CHANGES
MONTREAL, QUEBEC, August 6, 2024 – Valeo Pharma Inc. (TSX: VPH, OTCQB: VPHIF, FSE: VP2) (“ Valeo ” or the “ Company ”), a Canadian pharmaceutical company, today announced that the Company’s Chief …See details»
VALEO PHARMA ANNOUNCES ORGANIZATIONAL CHANGES AND …
Nov 20, 2023 · Valeo expects to decrease its operating expenses by more than $2.0 million, on an annualized basis, through reorganizing and streamlining its organizational structure and …See details»
Valeo Pharma - Crunchbase Company Profile & Funding
Valeo Pharma is a pharmaceutical company dedicated to bringing prescription products to the market. View contacts for Valeo Pharma to access new leads and connect with decision …See details»
Valeo Pharma - LinkedIn
Valeo Pharma is a fast growing Canadian pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Respiratory/Allergy, Ophthalmology...See details»
Valeo Pharma Announces Major Addition to its Senior ... - Newswire
Jan 18, 2021 · Valeo Pharma is a pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Neurodegenerative Diseases, …See details»
Valeo Pharma Reports on Launch of New Corporate Structure
Aug 16, 2021 · Valeo Pharma is a Canadian pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Respiratory …See details»
Board of Directors - Valeo Pharma
Mr. Léger is a seasoned pharmaceutical executive with pan-Canadian and U.S. experience in both the prescription pharmaceutical and consumer healthcare businesses. He has extensive …See details»
VALEO PHARMA INITIATES RESTRUCTURING PROCEEDINGS …
Oct 1, 2024 · Valeo Pharma Inc. (TSX: VPH) (FSE: VP2), a Canadian pharmaceutical company, announced today that the Québec Superior Court (Commercial Division) (the "Court") has …See details»
Valeo Pharma Inc., VPI Pharmaceuticals Inc./VPI Pharmaceutiques …
900 boul. De Maisonneuve O., Bureau 2300, Montréal, Québec, Canada, H3A 0A8See details»
The Company - Valeo Pharma
Rooted in specialty pharma, Valeo is growing Canadian healthcare by licensing and acquiring Canadian rights to commercial stage, innovative and proprietary drugs, with no development …See details»
Valeo Pharma Joins Innovative Medecines Canada - Newswire
May 17, 2021 · For more information, please visit www.valeopharma.com and follow us on LinkedIn and Twitter. Forward Looking StatementsSee details»
Valeo Pharma Reports its First Quarter 2021 Results and Highlights
Mar 31, 2021 · Valeo Pharma is a Canadian pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Respiratory …See details»
Valeo Pharma - Overview, News & Similar companies - ZoomInfo
Aug 5, 2024 · Valeo Pharma contact info: Phone number: (514) 694-0150 Website: www.valeopharma.com What does Valeo Pharma do? Valeo Pharma is a pharmaceutical …See details»
Investor Relations - Valeo Pharma
Valeo Pharma (CSE:VPH, OTCQB: VPHIF, FSE: VP2) is a Canadian pharmaceutical company focused on Respiratory, Neurology, Oncology and Specialty Products. Within these areas …See details»
Valeo Pharma Licenses Canadian Rights to Ametop™ Gel from
Apr 28, 2020 · Valeo Pharma is a specialty pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on …See details»
Financial Reports - Valeo Pharma
Valeo Pharma is committed to provide healthcare professionals and patients with innovative therapeutic solutions to improve quality of life.See details»
Valeo Pharma Reports its 2020 Fourth Quarter and Year-End
MONTREAL, Feb. 24, 2021 /CNW Telbec/ - Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian specialty pharmaceutical company, …See details»
Valeo Pharma Closes $11.5 Million Bought-Deal Public Offering ...
Jun 29, 2021 · Valeo is a pharmaceutical company dedicated to the commercialization of innovative prescription products with a focus on Respirology, Neurodegenerative Diseases, …See details»